These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1860132)

  • 1. Effectiveness of oral diclofenac in the acute treatment of common migraine attacks: a double-blind study versus placebo.
    Massiou H; Serrurier D; Lasserre O; Bousser MG
    Cephalalgia; 1991 May; 11(2):59-63. PubMed ID: 1860132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diclofenac-K (50 and 100 mg) and placebo in the acute treatment of migraine.
    Dahlöf C; Björkman R
    Cephalalgia; 1993 Apr; 13(2):117-23. PubMed ID: 8495453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramuscular treatment of migraine attacks using diclofenac sodium: a crossover clinical trial.
    Del Bene E; Poggioni M; Garagiola U; Maresca V
    J Int Med Res; 1987; 15(1):44-8. PubMed ID: 3545942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diclofenac epolamine is effective in the treatment of acute migraine attacks. A randomized, crossover, double blind, placebo-controlled, clinical study.
    Vécsei L; Gallacchi G; Sági I; Semjén J; Tajti J; Szok D; Müller M; Vadass P; Kerékgyártó M
    Cephalalgia; 2007 Jan; 27(1):29-34. PubMed ID: 17212680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
    Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH;
    Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of diclofenac sodium softgel 100 mg with or without caffeine 100 mg in migraine without aura: a randomized, double-blind, crossover study.
    Peroutka SJ; Lyon JA; Swarbrick J; Lipton RB; Kolodner K; Goldstein J
    Headache; 2004 Feb; 44(2):136-41. PubMed ID: 14756851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of diclofenac potassium sachets in migraine: a randomized, double-blind, cross-over study in comparison with diclofenac potassium tablets and placebo.
    Diener HC; Montagna P; Gács G; Lyczak P; Schumann G; Zöller B; Mulder LJ; Siegel J; Edson K
    Cephalalgia; 2006 May; 26(5):537-47. PubMed ID: 16674762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of a new powdered formulation of diclofenac potassium for oral solution for the acute treatment of migraine: results from the International Migraine Pain Assessment Clinical Trial (IMPACT).
    Lipton RB; Grosberg B; Singer RP; Pearlman SH; Sorrentino JV; Quiring JN; Saper JR
    Cephalalgia; 2010 Nov; 30(11):1336-45. PubMed ID: 20959428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined oral lysine acetylsalicylate and metoclopramide in the acute treatment of migraine: a multicentre double-blind placebo-controlled study.
    Chabriat H; Joire JE; Danchot J; Grippon P; Bousser MG
    Cephalalgia; 1994 Aug; 14(4):297-300. PubMed ID: 7954760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular tramadol vs. diclofenac sodium for the treatment of acute migraine attacks in emergency department: a prospective, randomised, double-blind study.
    Engindeniz Z; Demircan C; Karli N; Armagan E; Bulut M; Aydin T; Zarifoglu M
    J Headache Pain; 2005 Jun; 6(3):143-8. PubMed ID: 16355295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute migraine attack with diclofenac sodium: a double-blind study.
    Karachalios GN; Fotiadou A; Chrisikos N; Karabetsos A; Kehagioglou K
    Headache; 1992 Feb; 32(2):98-100. PubMed ID: 1551795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IM ketorolac vs diclofenac potassium powder for oral solution for the acute treatment of severe migraine: a randomized controlled trial.
    Engel ER; Cheng J
    Neurol Sci; 2020 Mar; 41(3):537-542. PubMed ID: 31833000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intramuscular diclofenac in the acute treatment of migraine: a double-blind placebo controlled study].
    Bigal ME; Bordini CA; Speciali JG
    Arq Neuropsiquiatr; 2002 Jun; 60(2-B):410-5. PubMed ID: 12131942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group.
    Savani N; Brautaset NJ; Reunanen M; Szirmai I; Ashford EA; Hassani H; Saiers J
    Int J Clin Pract Suppl; 1999 Aug; 105():7-15. PubMed ID: 10692717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of oral ketoprofen in acute migraine: a double-blind randomized clinical trial.
    Dib M; Massiou H; Weber M; Henry P; Garcia-Acosta S; Bousser MG;
    Neurology; 2002 Jun; 58(11):1660-5. PubMed ID: 12058095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-administered subcutaneous diclofenac sodium in acute migraine attack: A randomized, double-blind, placebo-controlled dose-finding pilot study.
    Geppetti P; De Cesaris F; Benemei S; Cortelli P; Cevoli S; Pierangeli G; Favoni V; Lisotto C; Usai S; Frediani F; Di Fiore P; D'Arrigo G; Tassorelli C; Sances G; Cainazzo MM; Baraldi C; Sarchielli P; Corbelli I; De Vanna G; Tedeschi G; Russo A;
    Cephalalgia; 2022 Sep; 42(10):1058-1070. PubMed ID: 35469478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.